FILIP JANKU to Injections, Intravenous
This is a "connection" page, showing publications FILIP JANKU has written about Injections, Intravenous.
Connection Strength
0.088
-
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement. Cancer Chemother Pharmacol. 2018 11; 82(5):877-885.
Score: 0.038
-
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer. Cancer Chemother Pharmacol. 2016 05; 77(5):1097-102.
Score: 0.032
-
A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer. Clin Cancer Res. 2006 Dec 01; 12(23):7071-8.
Score: 0.017